Shuttle Pharmaceuticals Holdings Inc (SHPH)

$4.23 -0.08 (-1.86%)
Market Cap 2.59M
Revenue (ttm) 0.00
Net Income (ttm) -11.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 15,800
Avg Vol 2,707,781
Day's Range N/A - N/A
Shares Out 637,000.00
Stochastic %K 84%
Beta 0.20
Analysts Strong Buy
Price Target N/A

Company Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240 403 4212
Address:
401 Professional Drive, Suite 260, Gaithersburg, United States
Gorline
Gorline Aug. 12 at 10:48 PM
$CDLX $PAVM $SHPH $XXII Wu Capital China has loaded heavy on ticker NAMI! Make sure to put NAMI on your watchlist as the chinese men added a heavy stake! NAMI has only 400 watchers and could be another chinese black swan short killer. Today I added a big position on NAMI hoping to sell for a big profit like the other china squeezes. Watch NAMI!🟧
0 · Reply
KTGAMBLESTOCKS
KTGAMBLESTOCKS Aug. 12 at 4:00 PM
$SHPH acquired some kind of data center campus. Under 3M market cap. $NBIS calls wow. $HIVE undervalued.
0 · Reply
ace6th
ace6th Aug. 11 at 4:52 PM
$SHPH 73% Shorted, what a time for a squeeze to happen
0 · Reply
Bazziggr
Bazziggr Aug. 10 at 3:04 PM
$SHPH SXTC
0 · Reply
KTGAMBLESTOCKS
KTGAMBLESTOCKS Aug. 7 at 5:52 PM
$SHPH run it
0 · Reply
takethemonayy
takethemonayy Aug. 7 at 5:10 PM
$SHPH
0 · Reply
MillionaireTrader555
MillionaireTrader555 Aug. 7 at 12:00 PM
$SHPH only a matter of time before this goes $4 to $20+ extreme low floater that hasn’t run yet!
0 · Reply
Skywalker86
Skywalker86 Aug. 6 at 6:20 PM
$SHPH shorts trying to take this down any type of buy volume flow will make this move fast
0 · Reply
TrustFundBaby
TrustFundBaby Aug. 6 at 6:13 PM
$SHPH $ENSC $VMAR Called both SHPH AND ENSC 🚀🚀 GET READY FOR $HYFM 🔥😠
0 · Reply
STACKD0E
STACKD0E Aug. 6 at 4:48 PM
$OESX $SHPH 🙃✨️
1 · Reply
Latest News on SHPH
United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site

Jun 26, 2026, 8:00 AM EDT - 6 weeks ago

United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site

United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting

Jun 25, 2026, 4:05 PM EDT - 6 weeks ago

United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

2026-06-10T23:50:59.000Z - 2 months ago

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time

Jun 9, 2026, 8:30 AM EDT - 2 months ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time

Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

May 14, 2026, 4:05 PM EDT - 3 months ago

Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

May 7, 2026, 2:02 PM EDT - 3 months ago

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation

May 1, 2026, 8:41 AM EDT - 3 months ago

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation

Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner

Apr 30, 2026, 4:05 PM EDT - 3 months ago

Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner

RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 27, 2026, 8:00 AM EDT - 4 months ago

RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 26, 2026, 4:05 PM EDT - 4 months ago

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public Offering

Mar 12, 2026, 8:30 AM EDT - 5 months ago

E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public Offering

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Mar 6, 2026, 8:00 AM EST - 5 months ago

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Jan 13, 2026, 4:00 PM EST - 7 months ago

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Shuttle Pharmaceuticals Acquires AI Health Platform

Nov 21, 2025, 9:30 AM EST - 9 months ago

Shuttle Pharmaceuticals Acquires AI Health Platform

Shuttle Pharmaceuticals files to sell 625,156 shares of common stock for holders

2025-11-18T22:05:15.000Z - 9 months ago

Shuttle Pharmaceuticals files to sell 625,156 shares of common stock for holders

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Nov 3, 2025, 7:00 AM EST - 10 months ago

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

Oct 22, 2025, 10:00 AM EDT - 10 months ago

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Oct 22, 2025, 7:00 AM EDT - 10 months ago

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

Oct 21, 2025, 5:55 PM EDT - 10 months ago

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform

Oct 21, 2025, 4:05 PM EDT - 10 months ago

Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform

Shuttle Pharmaceuticals announces extension of LOI with Molecule.ai

2025-10-10T14:25:15.000Z - 10 months ago

Shuttle Pharmaceuticals announces extension of LOI with Molecule.ai

Shuttle Executes LOI with Molecule.ai

Oct 10, 2025, 10:20 AM EDT - 10 months ago

Shuttle Executes LOI with Molecule.ai

Shuttle Pharmaceuticals to acquire Molecule.ai for $10M

2025-10-09T20:25:12.000Z - 10 months ago

Shuttle Pharmaceuticals to acquire Molecule.ai for $10M

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

Oct 9, 2025, 4:15 PM EDT - 10 months ago

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

Aug 14, 2025, 4:05 PM EDT - 1 year ago

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

Shuttle Pharmaceuticals files to sell 1.18M shares of common stock for holders

2025-08-05T10:16:04.000Z - 1 year ago

Shuttle Pharmaceuticals files to sell 1.18M shares of common stock for holders

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Jun 24, 2025, 4:10 PM EDT - 1 year ago

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

Jun 20, 2025, 3:55 PM EDT - 1 year ago

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

2025-06-13T23:50:22.000Z - 1 year ago

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

Shuttle Pharmaceuticals says reverse stock split to become effective June 16

2025-06-12T16:05:29.000Z - 1 year ago

Shuttle Pharmaceuticals says reverse stock split to become effective June 16

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

Jun 12, 2025, 12:00 PM EDT - 1 year ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

2025-06-12T12:45:38.000Z - 1 year ago

Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

Jun 12, 2025, 8:30 AM EDT - 1 year ago

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

Shuttle Pharmaceuticals appoints George Scorsis as chairman

2025-06-04T20:10:45.000Z - 1 year ago

Shuttle Pharmaceuticals appoints George Scorsis as chairman

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

Jun 4, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

Shuttle Pharma Ropidoxuridine Phase 2 trial nears 50% enrollment

2025-05-15T20:50:26.000Z - 1 year ago

Shuttle Pharma Ropidoxuridine Phase 2 trial nears 50% enrollment

Shuttle Pharma Provides Corporate Update

May 15, 2025, 4:45 PM EDT - 1 year ago

Shuttle Pharma Provides Corporate Update

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

May 8, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Apr 21, 2025, 4:15 PM EDT - 1 year ago

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Shuttle Pharmaceuticals files provisional patent application with USPTO

2025-04-10T20:10:54.000Z - 1 year ago

Shuttle Pharmaceuticals files provisional patent application with USPTO

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Apr 10, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

Mar 13, 2025, 4:10 PM EDT - 1 year ago

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

Shuttle Pharmaceuticals prices 19.17M shares at 30c per share in public offering

2025-03-12T13:30:38.000Z - 1 year ago

Shuttle Pharmaceuticals prices 19.17M shares at 30c per share in public offering

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

Mar 12, 2025, 9:24 AM EDT - 1 year ago

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO

2025-03-12T10:25:28.000Z - 1 year ago

Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Mar 12, 2025, 6:20 AM EDT - 1 year ago

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

Feb 26, 2025, 10:45 AM EST - 1 year ago

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

Shuttle reaches milestone in enrollment for Phase 2 trial of Ropidoxuridine

2025-01-21T14:15:45.000Z - 1 year ago

Shuttle reaches milestone in enrollment for Phase 2 trial of Ropidoxuridine

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Jan 7, 2025, 9:00 AM EST - 1 year ago

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF

2024-12-19T14:11:32.000Z - 1 year ago

Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF

Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line

2024-11-26T14:06:10.000Z - 1 year ago

Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Nov 26, 2024, 9:00 AM EST - 1 year ago

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

Nov 13, 2024, 5:00 PM EST - 1 year ago

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share

2024-10-30T01:10:10.000Z - 1 year ago

Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Oct 29, 2024, 9:05 PM EDT - 1 year ago

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Oct 28, 2024, 4:05 PM EDT - 1 year ago

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Sep 16, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

Sep 4, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Aug 26, 2024, 4:10 PM EDT - 2 years ago

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Aug 14, 2024, 4:10 PM EDT - 2 years ago

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

Jul 19, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

Jun 18, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 22, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

Shuttle Pharma Provides First Quarter 2024 Corporate Update

May 14, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides First Quarter 2024 Corporate Update

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Apr 23, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Apr 3, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

Mar 22, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

Gorline
Gorline Aug. 12 at 10:48 PM
$CDLX $PAVM $SHPH $XXII Wu Capital China has loaded heavy on ticker NAMI! Make sure to put NAMI on your watchlist as the chinese men added a heavy stake! NAMI has only 400 watchers and could be another chinese black swan short killer. Today I added a big position on NAMI hoping to sell for a big profit like the other china squeezes. Watch NAMI!🟧
0 · Reply
KTGAMBLESTOCKS
KTGAMBLESTOCKS Aug. 12 at 4:00 PM
$SHPH acquired some kind of data center campus. Under 3M market cap. $NBIS calls wow. $HIVE undervalued.
0 · Reply
ace6th
ace6th Aug. 11 at 4:52 PM
$SHPH 73% Shorted, what a time for a squeeze to happen
0 · Reply
Bazziggr
Bazziggr Aug. 10 at 3:04 PM
$SHPH SXTC
0 · Reply
KTGAMBLESTOCKS
KTGAMBLESTOCKS Aug. 7 at 5:52 PM
$SHPH run it
0 · Reply
takethemonayy
takethemonayy Aug. 7 at 5:10 PM
$SHPH
0 · Reply
MillionaireTrader555
MillionaireTrader555 Aug. 7 at 12:00 PM
$SHPH only a matter of time before this goes $4 to $20+ extreme low floater that hasn’t run yet!
0 · Reply
Skywalker86
Skywalker86 Aug. 6 at 6:20 PM
$SHPH shorts trying to take this down any type of buy volume flow will make this move fast
0 · Reply
TrustFundBaby
TrustFundBaby Aug. 6 at 6:13 PM
$SHPH $ENSC $VMAR Called both SHPH AND ENSC 🚀🚀 GET READY FOR $HYFM 🔥😠
0 · Reply
STACKD0E
STACKD0E Aug. 6 at 4:48 PM
$OESX $SHPH 🙃✨️
1 · Reply
serialdiluters
serialdiluters Aug. 6 at 1:28 PM
$SHPH ran +26% yesterday. 2 424B filings YTD. https://serialdiluters.com/t/SHPH/
0 · Reply
SlutGopher
SlutGopher Aug. 6 at 12:02 PM
$SHPH looks perplexing indeed
0 · Reply
FastTrader0
FastTrader0 Aug. 6 at 3:44 AM
$SHPH this is gonna run tomorrow
1 · Reply
Bigeyes2
Bigeyes2 Aug. 6 at 3:20 AM
$SHPH cup and handle
0 · Reply
ace6th
ace6th Aug. 5 at 11:19 PM
$SHPH The Borrow rate/fee is 400% +! + Micro Float! let her fly to $30.00 +
1 · Reply
Skywalker86
Skywalker86 Aug. 5 at 11:00 PM
$SHPH 🔥🩳
0 · Reply
boncuk
boncuk Aug. 5 at 10:06 PM
$SHPH @TempleofBoom @OvernightWatchmen I am not bot lol .
0 · Reply
topstockalerts
topstockalerts Aug. 5 at 8:08 PM
$SHPH this one seems determined to prove a point.
0 · Reply
TrustFundBaby
TrustFundBaby Aug. 5 at 7:52 PM
$SHPH $RAIN $MGN SHPH 50% gains! Next is $HYFM 🚀🚀
0 · Reply
Zskylar
Zskylar Aug. 5 at 6:42 PM
$SHPH wish would run like yxt
1 · Reply
Skywalker86
Skywalker86 Aug. 5 at 5:18 PM
$SHPH heavily shorted
1 · Reply
TrustFundBaby
TrustFundBaby Aug. 5 at 5:05 PM
$SHPH $AMIX MASSIVE GAINS ON BOTH! All profits to $HYFM next 🚀🚀
0 · Reply